Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management
by Henry Sutanto and Gatot Soegiarto
 
A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
by Anna Candoni and Gabriele Coppola
 
Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature
by Sasmith R. Menakuru, Adelina Priscu, Vijaypal Dhillon and Ahmed Salih
 
COVID-19-Associated Thrombotic Thrombocytopenic Purpura: A Case Report and Systematic Review
by Haseeb Chaudhary, Usama Nasir, Khezar Syed, Maria Labra, Christopher Reggio, Ansar Aziz, Parin Shah, Roopika Reddy and Navdeep Sangha
 
Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors
by Samuel Sarmiento Doncel, Gina Alejandra Díaz Mosquera, Javier Mauricio Cortes, Carol Agudelo Rico, Francisco Javier Meza Cadavid and Ronald Guillermo Peláez
 
Combination Therapies with Kinase Inhibitors for Acute Myeloid Leukemia Treatment
by Shinichiro Takahashi
 
Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
by Sang Ngoc Nguyen, Lam Tung Vu, Quang Van Vu, Tham Thi Tran and Vi Tuong Thi Dinh
 
Molecular Tumor Boards: The Next Step towards Precision Therapy in Cancer Care
by Angela Liu, Paige Vicenzi, Ishna Sharma, Kaci Orr, Christa Teller, Micha Koentz, Heidi Trinkman, Kelly Vallance and Anish Ray
 
Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
by Jesse Fishman, Seth Kuranz, Michael M. Yeh, Kaylen Brzozowski and Herman Chen
 
Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective
by Daniel Martínez-Carballeira, Ángel Bernardo, Alberto Caro, Inmaculada Soto and Laura Gutiérrez
Views Article
Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors
by Samuel Sarmiento Doncel, Gina Alejandra Díaz Mosquera, Javier Mauricio Cortes, Carol Agudelo Rico, Francisco Javier Meza Cadavid and Ronald Guillermo Peláez
Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective
by Daniel Martínez-Carballeira, Ángel Bernardo, Alberto Caro, Inmaculada Soto and Laura Gutiérrez
Reticulocyte Hemoglobin as a Screening Test for Iron Deficiency Anemia: A New Cut-Off
by Abdullah I. Aedh, Mohamed S. M. Khalil, Alaa S. Abd-Elkader, Mohamed M. El-Khawanky, Hamdan M. Alshehri, Amr Hussein, Ali A. Lafi Alghamdi and Abdulkarim Hasan
Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients
by Claudio Pellegrino, Giulia Dragonetti, Patrizia Chiusolo, Monica Rossi, Nicoletta Orlando and Luciana Teofili
Oral Manifestations: A Warning-Sign in Children with Hematological Disease Acute Lymphocytic Leukemia
by Sandra Clara Soares, Louis J. D. Roux, Ana Rita Castro, Cristina Cardoso Silva, Rita Rodrigues, Viviana M. P. Macho, Fátima Silva and Céu Costa
A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
by Anna Candoni and Gabriele Coppola
Late Presentation of Dyskeratosis Congenita: Germline Predisposition to Adult-Onset Secondary Acute Myeloid Leukemia
by Harry Ramos, Mai Mostafa Aly and Suresh Kumar Balasubramanian
Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management
by Henry Sutanto and Gatot Soegiarto
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments
by Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato and Andrea Messori
How I Manage Chronic Lymphocytic Leukemia
by Patrice Nasnas, Claudio Cerchione, Gerardo Musuraca, Giovanni Martinelli and Alessandra Ferrajoli
Downloads Article
Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors
by Samuel Sarmiento Doncel, Gina Alejandra Díaz Mosquera, Javier Mauricio Cortes, Carol Agudelo Rico, Francisco Javier Meza Cadavid and Ronald Guillermo Peláez
A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
by Anna Candoni and Gabriele Coppola
How I Manage Chronic Lymphocytic Leukemia
by Patrice Nasnas, Claudio Cerchione, Gerardo Musuraca, Giovanni Martinelli and Alessandra Ferrajoli
Oral Manifestations: A Warning-Sign in Children with Hematological Disease Acute Lymphocytic Leukemia
by Sandra Clara Soares, Louis J. D. Roux, Ana Rita Castro, Cristina Cardoso Silva, Rita Rodrigues, Viviana M. P. Macho, Fátima Silva and Céu Costa
Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
by Sang Ngoc Nguyen, Lam Tung Vu, Quang Van Vu, Tham Thi Tran and Vi Tuong Thi Dinh
Drug–Drug Interactions of FXI Inhibitors: Clinical Relevance
by Nicola Ferri, Elisa Colombo and Alberto Corsini
Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective
by Daniel Martínez-Carballeira, Ángel Bernardo, Alberto Caro, Inmaculada Soto and Laura Gutiérrez
Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma
by Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Atsushi Ito, Shunsuke Nagase, Hisanobu Miura, Giovanna Roncador, Lluis Colomo, Rifat Hamoudi, Elias Campo and Naoya Nakamura
Reticulocyte Hemoglobin as a Screening Test for Iron Deficiency Anemia: A New Cut-Off
by Abdullah I. Aedh, Mohamed S. M. Khalil, Alaa S. Abd-Elkader, Mohamed M. El-Khawanky, Hamdan M. Alshehri, Amr Hussein, Ali A. Lafi Alghamdi and Abdulkarim Hasan
Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
by Jesse Fishman, Seth Kuranz, Michael M. Yeh, Kaylen Brzozowski and Herman Chen
Back to TopTop